Finance

Lists
Why is NANO up 3.51%?
Dive Deeper
NANO:EPA
Nanobiotix SA
€21.24
+3.51%
(+0.72) 1D
Oct 9, 5:35:21 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for NANO...
Open
€20.98
High
€21.46
Low
€20.78
Mkt. cap
1.09B
Avg. vol.
171.98K
Volume
160.28K
52-wk high
€47.66
52-wk low
€13.10
EPS
-€1.09
Shares outstanding
50.83M
No. of employees
98
Open
€20.98
High
€21.46
Low
€20.78
Mkt. cap
1.09B
Avg. vol.
171.98K
Volume
160.28K
52-wk high
€47.66
52-wk low
€13.10
EPS
-€1.09
Shares outstanding
50.83M
No. of employees
98
News stories
From web sources and news partners
Profile
Nanobiotix is a biotechnology company that uses nanomedicine to develop new radiotherapy techniques for cancer patients. The company is headquartered in Paris, with additional corporate offices in New York and Massachusetts. Wikipedia
About Nanobiotix SA
CEOLaurent Levy
Employees98
Founded2003
Headquarters-
SectorBiotechnology
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.98M
2.98M
2.78M
2.78M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.29M
4.29M
6.36M
6.36M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.53M
4.53M
5.38M
5.38M
Operating expense
8.83M
8.83M
11.74M
11.74M
Total operating expenses
8.83M
8.83M
11.74M
11.74M
Operating income
-5.85M
-5.85M
-8.96M
-8.96M
Other non operating income
-8.50K
-8.50K
-1.00K
-1.00K
EBT including unusual items
-9.29M
-9.29M
-17.14M
-17.14M
EBT excluding unusual items
-8.57M
-8.57M
-16.56M
-16.56M
Income tax expense
-1.50K
-1.50K
8.00K
8.00K
Effective tax rate
0.02%
0.02%
-0.05%
-0.05%
Other operating expenses
-
-
-
-
Net income
-9.29M
-9.29M
-17.14M
-17.14M
Net profit margin
-311.97%
-311.97%
-617.69%
-617.69%
Earnings per share
-
-
-
-
Interest and investment income
193.50K
193.50K
338.50K
338.50K
Interest expense
-3.08M
-3.08M
-7.28M
-7.28M
Net interest expenses
-2.88M
-2.88M
-6.94M
-6.94M
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.79M
-5.79M
-8.84M
-8.84M
Gain or loss from assets sale
76.50K
76.50K
-
-
AI content may include mistakes. Learn more
Google apps